{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-026257","form_type":"8-K","ticker":"CLNN","cik":"0001822791","company_name":"Clene Inc.","filed_at":"2023-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.459063+00:00","generated_at":"2026-06-10T13:45:21.219324+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Clene appoints Prof. Kiernan and Dr. Desai to Board; Dr. Stevens retires","bullets":["Appointed Prof. Matthew Kiernan (neurology chair, University of Sydney) and Dr. Arjun Desai (INSIGHTEC exec) as Class II directors.","Each received 45,000 common stock options at $0.54 exercise price, vesting monthly over 36 months.","Director John H. Stevens retired immediately, not due to any disagreement; he served since 2015.","Jonathon T. Gay joined Audit Committee; Dr. Desai joined Compensation Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-026257","json":"https://secwatch.observer/filing/0001437749-23-026257.json","markdown":"https://secwatch.observer/filing/0001437749-23-026257.md","text":"https://secwatch.observer/filing/0001437749-23-026257.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/clnn20230914_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T13:45:21.219324+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"22c0a882f8","claim":"John H. Stevens retired as Class II Director at Clene Inc..","evidence_excerpt":"John H. Stevens, M.D., a Class II director of the Company, informed the Board of his decision to retire from the Board and all committees","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"},{"claim_id":"a80a44d17b","claim":"Matthew Kiernan was appointed as Class II Director at Clene Inc..","evidence_excerpt":"appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members of the Board, effective September 18, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"},{"claim_id":"f3993a1bf3","claim":"Arjun Desai was appointed as Class II Director at Clene Inc..","evidence_excerpt":"appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members of the Board, effective September 18, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}